Showing 11,741 - 11,760 results of 42,192 for search '(( 50 ((ng decrease) OR (((we decrease) OR (a decrease)))) ) OR ( a point decrease ))', query time: 1.16s Refine Results
  1. 11741

    Data_Sheet_1_RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis.DOCX by Alba Manresa-Arraut (5318861)

    Published 2018
    “…Our study demonstrates that RhoA is a central regulator of several archetypical T-cell responses, and furthermore points toward RhoA as a new potential therapeutic target in diseases such as MS, where T-cell activity plays a central role.…”
  2. 11742

    Image_2_RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis.JPEG by Alba Manresa-Arraut (5318861)

    Published 2018
    “…Our study demonstrates that RhoA is a central regulator of several archetypical T-cell responses, and furthermore points toward RhoA as a new potential therapeutic target in diseases such as MS, where T-cell activity plays a central role.…”
  3. 11743

    Image_1_RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis.JPEG by Alba Manresa-Arraut (5318861)

    Published 2018
    “…Our study demonstrates that RhoA is a central regulator of several archetypical T-cell responses, and furthermore points toward RhoA as a new potential therapeutic target in diseases such as MS, where T-cell activity plays a central role.…”
  4. 11744

    Image_4_RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis.JPEG by Alba Manresa-Arraut (5318861)

    Published 2018
    “…Our study demonstrates that RhoA is a central regulator of several archetypical T-cell responses, and furthermore points toward RhoA as a new potential therapeutic target in diseases such as MS, where T-cell activity plays a central role.…”
  5. 11745

    Scheffe post-hoc. by Nina Brkić-Jovanović (18886883)

    Published 2024
    “…In both therapy groups (RAL and DTG), there was no significant decrease in neurocognitive achievement on all used measures over a one-year follow-up in both therapy groups. …”
  6. 11746

    MANCOVA’s main and interactive effect results. by Nina Brkić-Jovanović (18886883)

    Published 2024
    “…In both therapy groups (RAL and DTG), there was no significant decrease in neurocognitive achievement on all used measures over a one-year follow-up in both therapy groups. …”
  7. 11747

    S1 File - by Nina Brkić-Jovanović (18886883)

    Published 2024
    “…In both therapy groups (RAL and DTG), there was no significant decrease in neurocognitive achievement on all used measures over a one-year follow-up in both therapy groups. …”
  8. 11748
  9. 11749
  10. 11750
  11. 11751
  12. 11752
  13. 11753

    Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5‑<i>a</i>]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators by Shuai Wang (109515)

    Published 2020
    “…In this work, we reported the structure-based design of triazolo­[1,5-<i>a</i>]­pyrimidines as new ABCB1 modulators, of which <b>WS-691</b> significantly increased sensitization of ABCB1-overexpressed SW620/Ad300 cells to paclitaxel (PTX) (IC<sub>50</sub> = 22.02 nM). …”
  14. 11754

    Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5‑<i>a</i>]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators by Shuai Wang (109515)

    Published 2020
    “…In this work, we reported the structure-based design of triazolo­[1,5-<i>a</i>]­pyrimidines as new ABCB1 modulators, of which <b>WS-691</b> significantly increased sensitization of ABCB1-overexpressed SW620/Ad300 cells to paclitaxel (PTX) (IC<sub>50</sub> = 22.02 nM). …”
  15. 11755

    Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5‑<i>a</i>]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators by Shuai Wang (109515)

    Published 2020
    “…In this work, we reported the structure-based design of triazolo­[1,5-<i>a</i>]­pyrimidines as new ABCB1 modulators, of which <b>WS-691</b> significantly increased sensitization of ABCB1-overexpressed SW620/Ad300 cells to paclitaxel (PTX) (IC<sub>50</sub> = 22.02 nM). …”
  16. 11756
  17. 11757
  18. 11758

    Stress-related candidate genes and functions. by Jacquelyn Y. Taylor (6386456)

    Published 2024
    “…<div><p>RiSE study aims to evaluate a race-based stress-reduction intervention as an effective strategy to improve coping and decrease stress-related symptoms, inflammatory burden, and modify DNA methylation of stress response-related genes in older AA women. …”
  19. 11759

    Conceptual model. by Jacquelyn Y. Taylor (6386456)

    Published 2024
    “…<div><p>RiSE study aims to evaluate a race-based stress-reduction intervention as an effective strategy to improve coping and decrease stress-related symptoms, inflammatory burden, and modify DNA methylation of stress response-related genes in older AA women. …”
  20. 11760

    DataSheet_2_Immunotherapeutic Effects of Different Doses of Mycobacterium tuberculosis ag85a/b DNA Vaccine Delivered by Electroporation.pdf by Yan Liang (139654)

    Published 2022
    “…</p>Methods<p>Ninety-six female BALB/c mice were challenged with 2×10<sup>4</sup> colony-forming units (CFUs) of MTB H<sub>37</sub>Rv through tail vein injection, then was treated with 10μg, 50μg, 100μg, and 200μg of Mycobacterium tuberculosis (MTB) ag85a/b chimeric DNA vaccine delivered by intramuscular injection (IM) and electroporation (EP), respectively. …”